References
- Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the diffuse endocrine system. Curr Opin Oncol 2008;20:1-12.
- Modlin IM, Sandor A. An analysis of 8305 cases of carcinoids tumors. Cancer 1997;79:813-829.
- Kim J, Lee WJ, Lee SH, Lee KB, Ryu JK, Kim YT, et al. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours. Dig Liver Dis 2011;43:965-970.
- Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO Classification of tumours of the digestive system. Histopathology 2020;76:182-188.
- de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, et al. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms. Neuroendocrinology 2017;105:412-425.
- Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol 2010;44:687-695.
- Nishime C, Ohnishi Y, Suemizu H, Tamaoki N, Kusumi T, Sato F. et al. In vivo chemotherapeutic profile of human gallbladder small cell carcinoma. Biomed Res 2008;29:251-256.
- Jun SR, Lee JM, Han JK, Choi BI. High-grade neuroendocrine carcinomas of the gallbladder and bile duct: report of four cases with pathological correlation. J Comput Assist Tomogr 2006;30:604-609.
- Lane JE, Walker AN, Ayers GW, Foster JL, Williams JT. Small-cell undifferentiated carcinoma of neuroendocrine type originating in the gallbladder. Curr Surg 2002;59:495-497.
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Neuroendocrine tumors. [Online, 16 December, 2017]. National Comprehensive Cancer Network.
- Klimstra D, Kloppel G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board, ed. Digestive system tumours WHO classification of tumours. 5th ed. IARC, 2019:16-19.
- Gastrointestinal Pathology Study Group of Korean Society of Pathologists; Cho MY, Kim JM, Sohn JH, Kim MJ, Kim KM, Kim WH, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat 2012;44:157-165.
- Kitano M, Yoshida T, Itonaga M, Tamura T, Hatamaru K, Yamashita Y. Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer. J Gastroenterol 2019;54:19-32.
- Burns WR, Edil BH. Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol 2012;13:24-34.
- Zheng Z, Chen C, Li B, Liu H, Zhou L, Zhang H, et al. Biliary neuroendocrine neoplasms: clinical profiles, management, and analysis of prognostic factors. Front Oncol 2019;9:38.
- Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, et al. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas 2012;41:840-844.
- Lee L, Ito T, Jensen RT. Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine neoplasm: recent advances and controversies. Expert Rev Anticancer Ther 2019;19:1028-1050.
- Jayant M, Punia R, Kaushik R, Sharma R, Sachdev A, Nadkarni NK, et al. Neuroendocrine tumors of the ampulla of Vater: presentation, pathology and prognosis: presentation. JOP 2012;13:263-267.
- Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 2010;17:2427-2443.
- Modlin IM, Kidd M, Drozdov I, Siddique ZL, Gustafsson BI. Pharmacotherapy of neuroendocrine cancers. Expert Opin Pharmacother 2008;9:2617-2626.
- Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol 2010;40:313-318.